Skip to content

Action of two forms of ozone therapy application on clinical and biochemical parameters after wisdom teeth extraction: clinical, triple blind and randomized study

Influence of two forms of ozone therapy application on clinical and biochemical parameters after third molar extractions: clinical, triple blind and randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8zypz4p
Enrollment
Unknown
Registered
2023-12-13
Start date
2023-07-29
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Interventions

The research project will consist of a randomized, triple-blind, split-mouth clinical study and will be submitted to the Local Research Ethics Committee, in which all volunteers, thirty-six participan
ozone oil (administration of six hundred milliequivalents of ozonized oil via subperiosteal route)
and control (without administration of therapy) administered in the immediate postoperative period, two and seven days. Surgical extraction of third molars with osteotomy, using local anesthetic mepiv
E06.892

Sponsors

Universidade Estadual Paulista Júlio de Mesquita Filho
Lead Sponsor
Faculdade de Odontologia de Araçatuba- FOA UNESP
Collaborator

Eligibility

Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients with favorable systemic and local health conditions; be between 16 and 35 years of age; both genders; with indication of tooth extraction of the lower third molars (elements 38 and 48), in position A or B and Pell & Gregory classification I or II, with at least 2/3 of the root formed

Exclusion criteria

Exclusion criteria: Mandibular third molars in position C and Pell & Gregory classification III; signs of local manifestations such as pericoronitis, cysts and odontogenic tumors associated or not with the third molar, trauma in the region, presence of infection or periodontal disease; patients with any systemic disease that interferes with the results of the procedure or who cannot use the drugs present in the study; presence of a history of hypersensitivity to drugs present in the study and to products used in the procedure, such as: 0.5% alcoholic chlorhexidine solution, 0.12% chlorhexidine digluconate solution and 2% mepivacaine hydrochloride solution with epinephrine 1:100,000; women who are menstruating, pregnant or breastfeeding during the study period; patients using medications to control psychiatric diseases, corticosteroids, estrogens and androgens

Design outcomes

Primary

MeasureTime frame
Clinically compare the effectiveness of protocols in controlling postoperative symptoms (pain) using the visual analogue scale (VAS) as a method, as follows: a sheet will be provided with a 10cm straight line on which the patient will be instructed to mark a point between the extremes "no pain" and "unbearable pain

Secondary

MeasureTime frame
To analyze the concentration of salivary biomarkers indicating tissue inflammation: total protein (PT), acid phosphatase (FA), alkaline phosphatase (FAL), aspartate aminotransferase (AST), alanine aminotransferase (ALT) present in the saliva of patients in each experimental group in each analysis time through biochemical evaluation;To evaluate whether ozone therapy is effective in modulating oxidative stress based on the analysis of the biomarker of thiobarbituric acid reactive species (TBARS)

Countries

Brazil

Contacts

Public ContactMonique da Costa

Faculdade de Odontologia de Araçatuba- FOA UNESP

moniquegc30@hotmail.com+55(11)995300490

Outcome results

None listed

Source: REBEC (via WHO ICTRP)